Cowingene Lyophilized Diarrhea Virus Panel 6 Detection Kit for Comprehensive Gastrointestinal Pathogen Screening

Acute diarrhea remains one of the most common infectious conditions worldwide, affecting both children and adults and placing a significant burden on healthcare systems. Rapid identification of causative viral pathogens is essential for effective clinical management, outbreak control, and public health surveillance. Molecular diagnostic technologies, particularly multiplex PCR-based assays, have become the gold standard for detecting gastrointestinal viruses with high sensitivity and specificity.

Cowin Gene is dedicated to advancing molecular POCT (Point-of-Care Testing) technology by providing fast, easy-to-operate, and highly sensitive diagnostic solutions for clinicians and patients. Its PCR-based core product line enables the rapid detection of multiple pathogens, including viruses, bacteria, and fungi, significantly improving diagnostic efficiency in clinical laboratories.

With a strong R&D team composed of senior scientists, engineers, and marketing experts, Cowin Gene continuously focuses on technological innovation and product optimization. The company’s R&D center is equipped with advanced laboratory instruments and operates under a strict quality management system to ensure that all products meet international in vitro diagnostic standards. Cowin Gene is committed to becoming a global leader in molecular POCT technology, delivering fast and reliable diagnostic solutions to improve global healthcare outcomes.

Cowingene Lyophilized Diarrhea Virus Panel 6 Detection Kit for Comprehensive Gastrointestinal Pathogen Screening

The Cowingene Diarrhea Virus Panel 6 Detection Kit (Lyophilized) is an in vitro diagnostic (IVD) PCR-based assay designed for the qualitative detection of six major viral pathogens responsible for acute gastroenteritis. These include Norovirus GI, Norovirus GII, Adenovirus, Sapovirus, Astrovirus, and Rotavirus Group 4.

This multiplex detection system allows simultaneous identification of multiple viral targets in a single or dual PCR analysis, significantly improving diagnostic efficiency and reducing laboratory workload. By consolidating six pathogens into one panel, it provides clinicians with a comprehensive tool for rapid gastrointestinal infection screening.

The kit is designed for use with feces and vomitus specimens, making it highly suitable for diagnosing acute diarrhea cases in both hospital and outpatient settings. With a limit of detection (LoD) of 400 copies/mL for all targets, it ensures high sensitivity even in low viral load samples.

High-Sensitivity 6-Target Diarrhea Virus Panel PCR Kit (Lyophilized) for Clinical Diagnosis

This high-sensitivity PCR detection kit is optimized for clinical laboratories requiring accurate and reproducible results in gastrointestinal pathogen detection. Its lyophilized format enhances reagent stability and simplifies storage and transportation.

The kit can be stored at 2–30°C for up to 18 months, eliminating the need for strict cold-chain logistics and making it suitable for diverse laboratory environments, including resource-limited regions. This stability ensures consistent performance across long-term storage and global distribution channels.

Cowin Gene’s strict quality control system ensures batch-to-batch consistency, enabling reliable diagnostic results for all six viral targets. This makes it an ideal solution for hospitals, disease control centers, and reference laboratories.

Advanced Cowingene Multiplex Diarrhea Virus Panel 6 Detection Kit for Rapid Stool Testing

This advanced multiplex detection kit is specifically designed for rapid stool testing in cases of suspected viral gastroenteritis. It enables simultaneous detection of multiple pathogens in a single workflow, reducing diagnostic time and improving clinical decision-making.

The kit supports validated specimen types including human stool and vomitus, ensuring broad clinical applicability. Specimens should be processed as soon as possible; if immediate testing is not feasible, they can be stored at 2–8°C for up to 7 days, below -18°C for up to 6 months, and below -70°C for long-term preservation.

The system is compatible with widely used real-time PCR instruments such as ABI 7500, Roche 480, and Bio-Rad CFX96, ensuring seamless integration into existing laboratory workflows.

Room-Temperature Stable Lyophilized Viral Panel Kit for Diarrhea Pathogen Identification

This lyophilized viral panel kit is designed for enhanced stability and operational flexibility. The freeze-dried reagent format allows storage at 2–30°C for up to 18 months, significantly reducing reliance on cold-chain logistics.

This feature makes it especially valuable for remote healthcare facilities, emergency outbreak response teams, and decentralized diagnostic laboratories. It ensures that high-quality molecular diagnostics can be performed even in environments with limited refrigeration infrastructure.

Once opened, Buffer Lyobeads remain stable for 7 days at 2–8°C, while PCR components can be stored for up to one month at -20°C under proper conditions. Strict handling guidelines, including protection from light and controlled freeze-thaw cycles, ensure optimal performance and reproducibility.

Cowin Gene’s molecular POCT products provide significant advantages in clinical diagnostics, including rapid detection time, simplified operation procedures, and high sensitivity performance. These characteristics make them highly suitable for hospitals, laboratories, and infectious disease monitoring centers.

The company’s core product line is based on PCR technology, enabling the rapid detection of a wide range of pathogens, including viruses, bacteria, and fungi. Each product is developed under a strict quality management system to ensure compliance with international in vitro diagnostic standards.

The Cowingene Diarrhea Virus Panel 6 Detection Kit is supported by recommended extraction reagents such as viral DNA/RNA columns and nucleic acid extraction kits, ensuring a complete and optimized workflow from sample preparation to final detection.

Cowin Gene continues to invest heavily in research and development to advance molecular POCT technology. With a vision to become a global innovation leader in in vitro diagnostics, the company is committed to delivering fast, reliable, and accessible diagnostic solutions that improve global healthcare and support effective disease control worldwide.